![Steven Moss](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven Moss
Fondateur chez Isomerase Therapeutics Ltd.
Postes actifs de Steven Moss
Sociétés | Poste | Début | Fin |
---|---|---|---|
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Directeur Technique/Scientifique/R&D | 01/01/2012 | - |
Fondateur | 01/01/2012 | - |
Historique de carrière de Steven Moss
Anciens postes connus de Steven Moss
Sociétés | Poste | Début | Fin |
---|---|---|---|
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Corporate Officer/Principal | 05/01/2010 | 12/03/2013 |
Formation de Steven Moss
University of Durham | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 4 |
Opérationnelle
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Biotica Technology Ltd.
![]() Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Isomerase Therapeutics Ltd.
![]() Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Steven Moss
- Expérience